BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 30385134)

  • 21. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue Plasminogen Activator Promotes TXNIP-NLRP3 Inflammasome Activation after Hyperglycemic Stroke in Mice.
    Ismael S; Nasoohi S; Yoo A; Ahmed HA; Ishrat T
    Mol Neurobiol; 2020 Jun; 57(6):2495-2508. PubMed ID: 32172516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vildagliptin inhibits high free fatty acid (FFA)-induced NLRP3 inflammasome activation in endothelial cells.
    Qi Y; Du X; Yao X; Zhao Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1067-1074. PubMed ID: 30945564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome.
    Sun X; Jiao X; Ma Y; Liu Y; Zhang L; He Y; Chen Y
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):63-70. PubMed ID: 27833015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium.
    Zhao Y; Li Q; Zhao W; Li J; Sun Y; Liu K; Liu B; Zhang N
    J Ethnopharmacol; 2015 Jul; 169():210-8. PubMed ID: 25922268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation.
    Zhang Y; Li X; Pitzer AL; Chen Y; Wang L; Li PL
    Antioxid Redox Signal; 2015 May; 22(13):1084-96. PubMed ID: 25739025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells.
    Hu Q; Zhang T; Yi L; Zhou X; Mi M
    Biofactors; 2018 Mar; 44(2):123-136. PubMed ID: 29193391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
    Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-11-5-27, a daidzein derivative, inhibits NLRP3 inflammasome activity via promoting autophagy.
    Zhou W; Liu X; Cheng K; Zhang X; Lu J; Hu R
    Exp Cell Res; 2017 Nov; 360(2):320-327. PubMed ID: 28942022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
    Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
    Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells.
    Tseng HH; Vong CT; Kwan YW; Lee SM; Hoi MP
    Sci Rep; 2016 Oct; 6():35016. PubMed ID: 27731349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway.
    Wang S; Zhao X; Yang S; Chen B; Shi J
    Chem Biol Interact; 2017 Dec; 278():48-53. PubMed ID: 29031534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ROS/TXNIP pathway contributes to thrombin induced NLRP3 inflammasome activation and cell apoptosis in microglia.
    Ye X; Zuo D; Yu L; Zhang L; Tang J; Cui C; Bao L; Zan K; Zhang Z; Yang X; Chen H; Tang H; Zu J; Shi H; Cui G
    Biochem Biophys Res Commun; 2017 Apr; 485(2):499-505. PubMed ID: 28202418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxin-interacting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells.
    Song J; Li J; Hou F; Wang X; Liu B
    Metabolism; 2015 Mar; 64(3):428-37. PubMed ID: 25499441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of high glucose-based peritoneal dialysis fluids on thioredoxin-interacting protein expression in human peritoneal mesothelial cells.
    Wu J; Zhang YF; Li JS; Zhu GL; Bi ZM; Li XY
    Int Immunopharmacol; 2019 Jan; 66():198-204. PubMed ID: 30471618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells.
    Du J; Wang Y; Tu Y; Guo Y; Sun X; Xu X; Liu X; Wang L; Qin X; Zhu M; Song E
    Exp Eye Res; 2020 Jul; 196():108065. PubMed ID: 32407725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1/NF-κB pathway.
    Wang ZK; Chen RR; Li JH; Chen JY; Li W; Niu XL; Wang FF; Wang J; Yang JX
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107086. PubMed ID: 33068868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling.
    Deng X; Huang W; Peng J; Zhu TT; Sun XL; Zhou XY; Yang H; Xiong JF; He HQ; Xu YH; He YZ
    Inflammation; 2018 Feb; 41(1):260-275. PubMed ID: 29098483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldose Reductase Mediates NLRP3 Inflammasome-Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice.
    Pal PB; Sonowal H; Shukla K; Srivastava SK; Ramana KV
    Endocrinology; 2017 Oct; 158(10):3661-3675. PubMed ID: 28938395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.